Michael Garnreiter Sells 1,000 Shares of Axon Enterprise, Inc. (NASDAQ:AXON) Stock

Axon Enterprise, Inc. (NASDAQ:AXON) Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $639.69, for a total value of $639,690.00. Following the transaction, the director now owns 24,259 shares in the company, valued at $15,518,239.71. This trade represents a 3.96 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Michael Garnreiter also recently made the following trade(s):

• On Tuesday, October 15th, Michael Garnreiter sold 1,000 shares of Axon Enterprise stock. The shares were sold at an average price of $437.98, for a total transaction of $437,980.00.

Axon Enterprise Price Performance

NASDAQ:AXON opened at $649.30 on Tuesday. The stock has a market capitalization of $49.51 billion, a PE ratio of 167.78, a P/E/G ratio of 14.19 and a beta of 1.01. Axon Enterprise, Inc. has a 1-year low of $241.72 and a 1-year high of $698.67. The firm has a fifty day simple moving average of $544.09 and a 200 day simple moving average of $408.89. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on AXON shares. Northland Securities boosted their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. JMP Securities boosted their price target on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a report on Thursday, October 31st. The Goldman Sachs Group increased their price objective on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Robert W. Baird boosted their target price on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Finally, Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. One research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $488.67.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. Quent Capital LLC raised its holdings in shares of Axon Enterprise by 1,875.0% in the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after purchasing an additional 75 shares during the period. Prestige Wealth Management Group LLC increased its position in Axon Enterprise by 115.8% during the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after buying an additional 44 shares during the last quarter. Blue Trust Inc. raised its stake in Axon Enterprise by 987.5% in the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock valued at $27,000 after buying an additional 79 shares during the period. Brooklyn Investment Group acquired a new stake in shares of Axon Enterprise in the third quarter valued at approximately $41,000. Finally, Planning Capital Management Corp boosted its stake in shares of Axon Enterprise by 83.3% during the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after acquiring an additional 55 shares during the period. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.